New Sepsis and Septic Shock Definitions: Clinical Implications and Controversies

Infectious Disease Clinics of North America

Volumn 31, Issue 3, 2017, Pages 397-413

  Rhee, Chanu ^a,b   Klompas, Michael ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clinical diagnosis; qSOFA; Sepsis; Septic shock; SIRS; SOFA

Indexed keywords

DISEASE CLASSIFICATION; HIGH RISK PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MODIFIED EARLY WARNING SCORE; MULTIPLE ORGAN FAILURE; NATIONAL EARLY WARNING SCORE; ORGAN DYSFUNCTION SCORE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THERAPY DELAY; TREATMENT PLANNING; VALIDATION STUDY; HOSPITAL EMERGENCY SERVICE; HOSPITAL MORTALITY; SEPSIS;

EMERGENCY SERVICE, HOSPITAL; HOSPITAL MORTALITY; HUMANS; ORGAN DYSFUNCTION SCORES; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 85021806483     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2017.05.001     Document Type: Review

References (77)

1. Bone, R.C., Balk, R.A., Cerra, F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:6 (1992), 1644–1655.
2. Singer, M., Deutschman, C.S., Seymour, C.W., et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016), 801–810.
3. Seymour, C.W., Liu, V.X., Iwashyna, T.J., et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016), 762–774.
4. Minino, A.M., Murphy, S.L., Death in the United States, 2010. NCHS Data Brief(99), 2012, 1–8.
5. Torio, C.M., Andrews, R.M., National inpatient hospital costs: the most expensive conditions by payer, 2011: statistical brief #160. 2006, Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville (MD).
6. Liu, V., Escobar, G.J., Greene, J.D., et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312:1 (2014), 90–92.
7. Winters, B.D., Eberlein, M., Leung, J., et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 38:5 (2010), 1276–1283.
8. Nesseler, N., Defontaine, A., Launey, Y., et al. Long-term mortality and quality of life after septic shock: a follow-up observational study. Intensive Care Med 39:5 (2013), 881–888.
9. Gaieski, D.F., Edwards, J.M., Kallan, M.J., et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 41:5 (2013), 1167–1174.
10. Martin, G.S., Mannino, D.M., Eaton, S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:16 (2003), 1546–1554.
11. Dombrovskiy, V.Y., Martin, A.A., Sunderram, J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:5 (2007), 1244–1250.
12. Rhee, C., Gohil, S., Klompas, M., Regulatory mandates for sepsis care–reasons for caution. N Engl J Med 370:18 (2014), 1673–1676.
13. Rhee, C., Murphy, M.V., Li, L., et al., for the Centers for Disease Control and Prevention Epicenters Program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis 60:1 (2015), 88–95.
14. Klompas, M., Rhee, C., The CMS sepsis mandate: right disease, wrong measure. Ann Intern Med 165:7 (2016), 517–518.
15. Phua, J., Ngerng, W., See, K., et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care, 17(5), 2013, R202.
16. Sands, K.E., Bates, D.W., Lanken, P.N., et al., Academic Medical Center Consortium Sepsis Project Working Group. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:3 (1997), 234–240.
17. Rhee, C., Kadri, S.S., Danner, R.L., et al. Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes. Crit Care, 20, 2016, 89.
18. Angus, D.C., Seymour, C.W., Coopersmith, C.M., et al. A framework for the development and interpretation of different sepsis definitions and clinical criteria. Crit Care Med 44:3 (2016), e113–e121.
19. Levy, M.M., Fink, M.P., Marshall, J.C., et al., SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:4 (2003), 1250–1256.
20. Dellinger, R.P., Levy, M.M., Rhodes, A., et al., Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:2 (2013), 580–637.
21. Vincent, J.L., Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 25:2 (1997), 372–374.
22. Churpek, M.M., Zadravecz, F.J., Winslow, C., et al. Incidence and prognostic value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med 192:8 (2015), 958–964.
23. Kaukonen, K.M., Bailey, M., Pilcher, D., et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 372:17 (2015), 1629–1638.
24. Shankar-Hari, M., Deutschman, C.S., Singer, M., Do we need a new definition of sepsis?. Intensive Care Med 41:5 (2015), 909–911.
25. Vincent, J.L., Moreno, R., Takala, J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:7 (1996), 707–710.
26. Le Gall, J.R., Klar, J., Lemeshow, S., et al. The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:10 (1996), 802–810.
27. Vincent, J.L., Martin, G.S., Levy, M.M., qSOFA does not replace SIRS in the definition of sepsis. Crit Care, 20(1), 2016, 210.
28. Shankar-Hari, M., Phillips, G.S., Levy, M.L., et al., Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:8 (2016), 775–787.
29. Freund, Y., Lemachatti, N., Krastinova, E., et al., for the French Society of Emergency Medicine Collaborators Group. Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:3 (2017), 301–308.
30. Raith, E.P., Udy, A.A., Bailey, M., et al., for the Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE). Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the Intensive Care Unit. JAMA 317:3 (2017), 290–300.
31. Rhee, C., Murphy, M.V., Li, L., et al., Centers for Disease Control and Prevention Epicenters Program. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: a retrospective study. Crit Care, 19, 2015, 338.
32. Kadri, S.S., Rhee, C., Strich, J.R., et al. Estimating ten-year trends in septic shock incidence and mortality in united states academic medical centers using clinical data. Chest 151:2 (2017), 278–285.
33. Simpson, S.Q., New sepsis criteria: a change we should not make. Chest 149:5 (2016), 1117–1118.
34. Cortes-Puch, I., Hartog, C.S., Opening the debate on the new sepsis definition change is not necessarily progress: revision of the sepsis definition should be based on new scientific insights. Am J Respir Crit Care Med 194:1 (2016), 16–18.
35. Levy, M.M., Rhodes, A., Phillips, G.S., et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 43:1 (2015), 3–12.
36. Ferrer, R., Artigas, A., Levy, M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:19 (2008), 2294–2303.
37. Miller, R.R. 3rd, Dong, L., Nelson, N.C., et al., Intermountain Healthcare Intensive Medicine Clinical Program. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med 188:1 (2013), 77–82.
38. Stevenson, E.K., Rubenstein, A.R., Radin, G.T., et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med 42:3 (2014), 625–631.
39. Kaukonen, K.M., Bailey, M., Suzuki, S., et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 311:13 (2014), 1308–1316.
40. Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:6 (2006), 1589–1596.
41. Gaieski, D.F., Mikkelsen, M.E., Band, R.A., et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:4 (2010), 1045–1053.
42. Beck, V., Chateau, D., Bryson, G.L., et al., Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care, 18(3), 2014, R97.
43. Waechter, J., Kumar, A., Lapinsky, S.E., et al., Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med 42:10 (2014), 2158–2168.
44. Bai, X., Yu, W., Ji, W., et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care, 18(5), 2014, 532.
45. Pro, C.I., Yealy, D.M., Kellum, J.A., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:18 (2014), 1683–1693.
46. ARISE Investigators, ANZICS Clinical Trials Group, Peake, S.L., Delaney, A., Bailey, M., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:16 (2014), 1496–1506.
47. Mouncey, P.R., Osborn, T.M., Power, G.S., et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:14 (2015), 1301–1311.
48. Lilly, C.M., The ProCESS trial–a new era of sepsis management. N Engl J Med 370:18 (2014), 1750–1751.
49. Levy, M.M., Dellinger, R.P., Townsend, S.R., et al. The Surviving Sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36:2 (2010), 222–231.
50. Rohde, J.M., Odden, A.J., Bonham, C., et al. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 8:5 (2013), 243–247.
51. De Backer, D., Biston, P., Devriendt, J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:9 (2010), 779–789.
52. Vail, E.A., Gershengorn, H.B., Hua, M., et al. Epidemiology of vasopressin use for adults with septic shock. Ann Am Thorac Soc 13:10 (2016), 1760–1767.
53. Rhee, C., Using procalcitonin to guide antibiotic therapy. Open Forum Infect Dis, 4(1), 2016, ofw249.
54. Liesenfeld, O., Lehman, L., Hunfeld, K.P., et al. Molecular diagnosis of sepsis: new aspects and recent developments. Eur J Microbiol Immunol (Bp) 4:1 (2014), 1–25.
55. Poeze, M., Ramsay, G., Gerlach, H., et al. An international sepsis survey: a study of doctors’ knowledge and perception about sepsis. Crit Care 8:6 (2004), R409–R413.
56. Townsend, S.R., Rivers, E., Tefera, L., Definitions for sepsis and septic shock. JAMA 316:4 (2016), 457–458.
57. Rangel-Frausto, M.S., Pittet, D., Costigan, M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:2 (1995), 117–123.
58. Brun-Buisson, C., The epidemiology of the systemic inflammatory response. Intensive Care Med 26:Suppl 1 (2000), S64–S74.
59. Williams, J.M., Greenslade, J.H., McKenzie, J.V., et al. Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest 151:3 (2017), 586–596.
60. Churpek, M.M., Snyder, A., Han, X., et al. Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med 195:7 (2017), 906–911.
61. Ho, K.M., Lan, N.S., Combining quick sequential organ failure assessment with plasma lactate concentration is comparable to standard sequential organ failure assessment score in predicting mortality of patients with and without suspected infection. J Crit Care 38 (2016), 1–5.
62. Howell, M.D., Donnino, M., Clardy, P., et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 33:11 (2007), 1892–1899.
63. Lokhandwala, S., Moskowitz, A., Lawniczak, R., et al. Disease heterogeneity and risk stratification in sepsis-related occult hypoperfusion: a retrospective cohort study. J Crit Care 30:3 (2015), 531–536.
64. Mikkelsen, M.E., Miltiades, A.N., Gaieski, D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:5 (2009), 1670–1677.
65. Jones, A.E., Puskarich, M.A., Is lactate the “Holy Grail” of biomarkers for sepsis prognosis?. Crit Care Med 37:5 (2009), 1812–1813.
66. Nguyen, H.B., Rivers, E.P., Knoblich, B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32:8 (2004), 1637–1642.
67. Trzeciak, S., Dellinger, R.P., Chansky, M.E., et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 33:6 (2007), 970–977.
68. Shapiro, N.I., Howell, M.D., Talmor, D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45:5 (2005), 524–528.
69. Jansen, T.C., van Bommel, J., Schoonderbeek, F.J., et al., LACTATE Study Group. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 182:6 (2010), 752–761.
70. Jones, A.E., Shapiro, N.I., Trzeciak, S., et al., Emergency Medicine Shock Research Network Investigators. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303:8 (2010), 739–746.
71. Singer, A.J., Taylor, M., LeBlanc, D., et al. ED bedside point-of-care lactate in patients with suspected sepsis is associated with reduced time to IV fluids and mortality. Am J Emerg Med 32:9 (2014), 1120–1124.
72. Surviving Sepsis Campaign. The Surviving Sepsis Campaign responds to Sepsis-3. 2016. Available at: http://www.survivingsepsis.org/SiteCollectionDocuments/SSC-Statements-Sepsis-Definitions-3-2016.pdf. Accessed December 4, 2016.
73. Vincent, J.L., de Mendonca, A., Cantraine, F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on “Sepsis-related Problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:11 (1998), 1793–1800.
74. Ferreira, F.L., Bota, D.P., Bross, A., et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286:14 (2001), 1754–1758.
75. Vincent, J.L., Moreno, R., Clinical review: scoring systems in the critically ill. Crit Care, 14(2), 2010, 207.
76. Seymour, C.W., Coopersmith, C.M., Deutschman, C.S., et al. Application of a framework to assess the usefulness of alternative sepsis criteria. Crit Care Med 44:3 (2016), e122–e130.
77. Rhee, C., Kadri, S., Huang, S.S., et al. Objective sepsis surveillance using electronic clinical data. Infect Control Hosp Epidemiol 37:2 (2016), 163–171.